PT

Padma Tripathi

Active Director Designated Partner DIN 08775423
DIN 08775423 First appointment Jun 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Padma Tripathi

Data last updated:

Padma Tripathi is a Designated Partner at Grivety Pharma Llp (since 2020). The company operates in Business Services.

DIN 08775423
Primary Designation Designated Partner
Industry Business Services
First Appointment 29 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Jun 20202020Active

Board colleagues of Padma Tripathi

NameDINCompanyDesignation
Om Tripathi08775362Grivety Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Grivety Pharma Llp
Premium access

Shareholding and investment profile for Padma Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Padma Tripathi

Padma Tripathi currently holds 1 directorship: Grivety Pharma Llp (Designated Partner, since 29 Jun 2020).

Padma Tripathi was first appointed on 29 Jun 2020 as Designated Partner at Grivety Pharma Llp.

The current boards of Padma Tripathi's companies include Om Tripathi (Grivety Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available